Motor Neurone Disease Trial, Recruiting (NCT07295990)

Motor Neurone Disease Trial, Recruiting NCT07295990 Sponsor: Nova Southeastern University Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07295990 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with ALS (also known as Lou Gehrig's disease), whether possible, probable, or confirmed
You have not previously done any tongue strengthening exercises
Your tongue strength is weaker than what is considered normal for your age group
You scored less than 3 on a swallowing difficulty questionnaire called the EAT-10 (meaning your swallowing difficulties are minimal or none at this time)

Who may not be able to join:

You have had a stroke
You have had a significant head injury
You have or have had cancer in the head or neck area
You have a tracheostomy (a breathing tube placed in your throat)
You have another neurological condition alongside ALS
You have recently had oral surgery (routine dental work is generally acceptable — confirm with trial site)
You are unable to push your tongue against a special pressure-measuring device
You are currently taking part in another clinical trial that could affect the results of this study
You are not able to eat or drink anything by mouth
You have completely lost the ability to speak (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lauren Tabor Gray, Ph.D., Neuroscience Institute, Cathy J. Husman ALS Center

Phone: 17863994053

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07295990

Sponsor: Nova Southeastern University

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: 17863994053

More information: https://clinicaltrials.gov/study/NCT07295990

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with ALS (also known as Lou Gehrig's disease), whether possible, probable, or confirmed
You have not previously done any tongue strengthening exercises
Your tongue strength is weaker than what is considered normal for your age group
You scored less than 3 on a swallowing difficulty questionnaire called the EAT-10 (meaning your swallowing difficulties are minimal or none at this time)

Who may not be able to join:

You have had a stroke
You have had a significant head injury
You have or have had cancer in the head or neck area
You have a tracheostomy (a breathing tube placed in your throat)
You have another neurological condition alongside ALS
You have recently had oral surgery (routine dental work is generally acceptable — confirm with trial site)
You are unable to push your tongue against a special pressure-measuring device
You are currently taking part in another clinical trial that could affect the results of this study
You are not able to eat or drink anything by mouth
You have completely lost the ability to speak (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nova Southeastern University

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Maximum Anterior Isometric Lingual Pressure Measured Using the TongueMeter Device; Videofluoroscopic Swallow Study

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov